PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.640.06 (1.08%)
5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.41%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.38%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
18.84%
EBIT growth 1.25-1.5x STERV.HE's 14.51%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
18.84%
Operating income growth 1.25-1.5x STERV.HE's 14.51%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
37.56%
Positive net income growth while STERV.HE is negative. John Neff might see a big relative performance advantage.
33.33%
Positive EPS growth while STERV.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
33.33%
Positive diluted EPS growth while STERV.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
3.17%
Share change of 3.17% while STERV.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
3.17%
Slight or no buyback while STERV.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
48.48%
OCF growth 1.25-1.5x STERV.HE's 43.16%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
90.35%
FCF growth 1.25-1.5x STERV.HE's 74.38%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
-32.26%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-5.25%
Negative 5Y CAGR while STERV.HE stands at 1.13%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-11.00%
Negative 3Y CAGR while STERV.HE stands at 3.40%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-29.11%
Negative 10Y OCF/share CAGR while STERV.HE stands at 64.45%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
520.62%
5Y OCF/share CAGR above 1.5x STERV.HE's 43.16%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-45.68%
Negative 3Y OCF/share CAGR while STERV.HE stands at 3.82%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
166.67%
Net income/share CAGR at 50-75% of STERV.HE's 280.29%. Martin Whitman might question if the firm’s product or cost base lags behind.
700.00%
5Y net income/share CAGR above 1.5x STERV.HE's 160.98%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
100.00%
3Y net income/share CAGR 1.25-1.5x STERV.HE's 72.58%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
54.65%
5Y equity/share CAGR above 1.5x STERV.HE's 19.61%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
16.80%
3Y equity/share CAGR at 50-75% of STERV.HE's 30.73%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.70%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
3.35%
Inventory growth well above STERV.HE's 5.85%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.19%
Asset growth at 50-75% of STERV.HE's 5.02%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
4.43%
50-75% of STERV.HE's 6.22%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-2.92%
We’re deleveraging while STERV.HE stands at 0.47%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-9.45%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.